Council Members in this Study Group: 450
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Leading institutions connect with members of this Study Group through GLG
Partner and Rheumatologist
San Diego Arthritis Medical Clinic ![]()
Ara Dikranian, MD, is Partner and Rheumatologist at San Diego Arthritis Medical Clinic, a single-specialty private practice in San Diego, California. Dr. Dikranian is board certified in internal medicine and rheumatology. He completed his rheumatology training at the University of California San Diego....
Daniel Wynn, MDDirector of Clinical Research
CONSULTANTS IN NEUROLOGY LTD ![]()
Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke,chronic...
Marina Raikhel, MDDirector
TORRANCE MEMORIAL MEDICAL CENTER ![]()
Marina Raikhel, MD, is an active family practitioner with a particular interest in primary care and ob/gyn focus. She has expertise in the treatment of a wide variety of internal medicine conditions, with special focus on diabetes, hypertension, obesity, anxiety, and depression. She is Director ofTorrance...
David Portman, MDDirector
COLUMBUS CENTER FOR WOMENS HEALTH RESEARCH ![]()
David Portman, MD, is Director and Principal Investigator of the Columbus Center for Women's Health Research. Dr. Portman is also a Clincial Investigator at The Ohio State University. He has conducted over 100 clinical studies in areas of contraception, osteoporosis, menopause, and sexual dysfunction...
Chief of Psychiatry and Psychology
CHILDREN'S HOSPITAL OF MICHIGAN ![]()
David Rosenberg, MD, is a tenured Professor and Miriam L Hamburger Endowed Chair of Psychiatry at Wayne State University and the Children's Hospital of Michigan. He is a board certified general and adult psychiatrist and pediatric psychiatrist. Dr. Rosenberg has authored first ever textbook on pediatric...
John Litton Jr., MDChief Executive Officer and President
Litton Family Medicine, PC ![]()
J. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...
Amit Vijapura, MDOwner
AMIT VIJAPURA MD ![]()
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Psychiatrist
North Scottsdale Psychiatric Specialists ![]()
Robert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's re-psychotherapy and psychopharmacology and thetreatment...
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
We need to learn more about ProSavin Phase I/II Trial in Parkinson’s disease
October 20, 2009
Oxford BioMedica Announces Update on ProSavin® Phase I/II Trial in Parkinsons Disease And Publication of Preclinical Results | www.pipelinereview.com
This is very interesting news. However, in my judgment it is too early to make a final conclusion concerning this clinical trial. Because it should be taken into account that the growing body of evidence clearly indicates that oxidative stress induced mitochondrial failure appeared to be one of the...
Amyloid Beta does not correlate to Alzheimer Disease.
October 12, 2009
Bayer Schering ties-up with AC Immune for trial in Alzheimer´s disease | www.pharmabiz.com
The finding of amyloid-beta (Aβ) deposition in AD brains after death led to the so-called “amyloid hypothesis”. We have extensively reviewed the literature which claims that AD is caused by the deposition of Aβ within structures called senile plaques that invade AD brains and that such plaque formation...
Antidepressants Vary More in Side Effects, Not Efficacy
August 30, 2009
2nd Generation Antidepressants Prove Effective | health.usnews.com
[SIDE EFFECTS] The main differences among the newer antidepressants are side effects and drug interactions. See the Commentary for a drug-by-drug list of these key differences. [PCP's] This review comes from a group of primary care docs, which is important because most depression is treated by PCPs....
State Medicaid Cuts May Limit Market for New Antipsychotic Lurasidone
August 30, 2009
LURASIDONE DEMONSTRATED EFFICACY IN TREATING PATIENTS WITH SCHIZOPHRENIA IN PIVOTAL PHASE 3 STUDY | www.pipelinereview.com
Lurasidone is an atypical antipsychotic owned by Dainippon Sumitomo Pharma. Phase 3 PEARL 1 Study: 6-week, multi-site, double-blind placebo-controlled trial in 500 pts with DSM4 schizophrenia with PANSS score greater than 80. RESULTS: 80mg dose was superior to placebo; 40mg & 120mg was not....
Lurasidone will be an important new option for the treatment of Schizophrenia
August 29, 2009
LURASIDONE DEMONSTRATED EFFICACY IN TREATING PATIENTS WITH SCHIZOPHRENIA IN PIVOTAL PHASE 3 STUDY | www.pipelinereview.com
After much disappointment over the current Atypical Antipsychotics , Lurasidone shows great promise for treatment refractory Schizophrenics.
| Study Group Name | No. Members |
|---|---|
| SSRI Prescribers (US) | 278 |
| Psychiatrists (US) | 1155 |
| Psychiatrists | 1554 |
| Physicians who Treat Insomnia (US) | 548 |
| Physicians who Treat ADHD (US) | 459 |
| Physicians who Treat Schizophrenia (US) | 371 |
| Ambien Prescribers (US) | 321 |